Sagitta Pharma embarks on a new capital-raising operation !

Isatis Capital is supporting the capital restructuring of Sagitta Pharma, alongside Andera Partners and BNP Paribas Développement. This operation enables the group’s CEO and key executives to take full control, reaffirming their commitment to the company’s long-term vision. It strengthens their ability to remain close to pharmacists, respond quickly to their needs, and expand a complete, high-quality range of services. By combining strategic leadership with operational expertise, the team aims to drive sustainable growth and reinforce Sagitta Pharma’s position as a trusted partner in the pharmaceutical sector.

A controlled and bold growth trajectory

Since its founding in 2009 by Jérôme Brunet, Sagitta Pharma has established itself as a key player in pharmaceutical distribution and services for pharmacies. Leveraging an integrated model that combines purchasing center and wholesale distributor activities, supported by a semi-automated logistics platform and a robust digital infrastructure, Sagitta Pharma offers clients a wide range of products with high availability, along with innovative complementary services.

Over the past five years, under the guidance of Isatis Capital, Sagitta Pharma has experienced exceptional growth, quadrupling its revenue to over €200 million. This success is driven by a transparent offering and high-quality support for pharmacists. The group has also expanded its regional presence through two strategic acquisitions in Nouvelle-Aquitaine and Occitanie, and has built lasting partnerships with more than 70 pharmacy networks, now serving over 3,000 client pharmacies.

A promising strategic evolution

This capital restructuring allows Jérôme Brunet and his management team to take full control of the group. It strengthens Sagitta Pharma’s independence and consolidates its ability to pursue its ambitious strategic plan.

The company reaffirms its commitment to continued growth while preserving its entrepreneurial culture and close ties to the field. The goal is to double the size of the group in the medium term by expanding its regional network to reach 6,000 pharmacies and executing targeted acquisitions to enhance its value proposition.

As a long-standing investor, Isatis Capital is proud to support Sagitta Pharma and its founder Jérôme Brunet in this new capital initiative.

This new milestone reflects our ongoing commitment to invest in our current solution to strengthen our closeness with pharmacists. We are determined to develop a complete and optimal range of services, tailored to meet the specific needs of our peers.